Shu Li

Dr. Shu Li

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2023 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
MAMagdy M. Abdelquader
Magdy M. Abdelquader
SLShu Li
Shu Li
GAGavin Andrews
Gavin Andrews
David JonesDavid Jones
David Jones

22 November 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
SLShu Li
Shu Li
TYTao Yu
Tao Yu
YTYiwei Tian
Yiwei Tian
CLColette Lagan
Colette Lagan
DJDavid S. Jones
David S. Jones
GAGavin Andrews
Gavin Andrews

1 January 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SLShu Li
Shu Li
ACAlice Culkin
Alice Culkin
DJDavid S. Jones
David S. Jones
GAGavin P. Andrews
Gavin P. Andrews

5 December 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YTYiwei Tian
Yiwei Tian
DJDavid S. Jones
David S. Jones
CDConor Donnelly
Conor Donnelly
TBTimothy Brannigan
Timothy Brannigan
SLShu Li
Shu Li
GAGavin Andrews
Gavin Andrews

31 January 2019 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
GAGavin Andrews
Gavin Andrews
SLShu Li
Shu Li
AAAmmar Almajaan
Ammar Almajaan
TYTao Yu
Tao Yu
LMLuigi Martini
Luigi Martini
DJDavid S. Jones
David S. Jones

21 November 2019 in Food & Nutrition Research
Verified
Journal Article
Open access
PDF file
MCMichael T.D. Campbell
Michael T.D. Campbell
DJDavid S. Jones
David S. Jones
GAGavin P. Andrews
Gavin P. Andrews
SLShu Li
Shu Li
Nicotinamide riboside (NR), a newly recognised form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD+), has been demonstrated to show therapeutic potential and the possibility of becoming a drug compound in addition to its proven role in rejuvenating ageing cells in mice. However, current literature is devoid of information relating to the physicochemical characterisation of NR and its respective impact upon formulation and final product processing. Here we report physicochemical properties of NR including pKa, log P, solubility, melting point, degradation mechanics, and kinetics, with a special focus on its stability under thermal and physiologically relevant conditions. A simple and rapid HPLC method confirms a base-catalysed hydrolysis degradation of NRCl to nicotinamide and sugar in simulated gastrointestinal (GI) fluids. Given the antagonising effect of nicotinamide against NR, the presented data have a profound impact on how NRCl should be handled both during formulation and storage to prevent formation and to limit accumulation of nicotinamide. The innovative combinatorial use of 1H NMR and Differential Scanning Calorimetry (DSC) was employed to investigate thermal events during NR melting. NRCl degrades upon melting and in solution undergoes hydrolysis in a buffer and in simulated intestinal environments. The results suggest that a proper and evidence-based formulation of NRCl is vital to enable further investigation and clinical analysis of this promising and novel nutrient. Any formulation would need to promote the stability of NRCl and protect it from hostile environments to prevent the accumulation of a potentially antagonistic degradation product. With the current work, we have filled a niche but vital gap in NR literature and the data presented may prove useful in furthering the understanding, specifically the formulation and processing of NRCl.